Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses from the FIGARO-DKD TrialCirculation 2021 Nov 13;[EPub Ahead of Print], G Filippatos, SD Anker, R Agarwal, LM Ruilope, P Rossing, GL Bakris, C Tasto, A Joseph, P Kolkhof, A Lage, B Pitt
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.